CMA Veterinary Pricing Transparency: A Step-by-Step Compliance Checklist

Why this checklist exists

The Competition and Markets Authority's Final Report on the veterinary sector, published in March 2026, set out a package of mandatory remedies covering pricing transparency, treatment cost estimates, ownership disclosure, and consumer protection. The CMA made the Order implementing these remedies, the Veterinary Services Market Investigation Order 2026, on 22 September 2026, and it came into force the next day. That is when the rules became binding, not a compliance date. Each remedy has its own compliance date in the Order, split by business size, and for an independent practice those dates fall between 22 March 2027 and 22 September 2027.

Order made — and the deadlines are further out than most coverage suggests. The Order is in force, but each duty applies only from its own compliance date. For a business with fewer than 15 first-opinion practices and/or out-of-hours centres — almost every independent — the earliest (price lists, ownership disclosure, complaints) is 22 March 2027 and the latest (estimates, itemised bills, prescription fee cap) is 22 September 2027. For most remedies larger groups run 3 to 6 months ahead of that, but ownership disclosure and the complaints process share one date for every size.

For practice managers, this is compliance on a staged timeline whose first deadlines are still months away. That is the useful thing about it: the whole package can be sequenced deliberately rather than scrambled. The earlier post What the CMA Veterinary Reforms Mean for Independent Practices explained the headline requirements. This guide is the practical checklist — what you need in place, in what order, before the deadline. For the complete six-remedy map rather than the checklist form, see the full CMA veterinary regulations overview.

If you'd rather work through the compliance status interactively, the CMA Compliance Self-Assessment tool walks through each requirement and flags gaps. This page is the framework the tool is built on.

How the remedies group practically

The remedies fall into five practical workstreams, each requiring different operational changes:

1. Pricing transparency on the website and in-practice
2. Itemised billing and estimates
3. Ownership and corporate disclosure
4. Prescription, dispensing, and treatment information
5. Complaints and dispute resolution

The checklist below is grouped by workstream. Each item is what an enforcing authority will expect to see evidence of.

Workstream 1: pricing transparency

Website price list

• Standardised price list published on practice website
• Covers every item in the Order's Schedule 1 that you offer — 36 items across consultation and preventative care, prescription and dispensing fees, surgeries and treatments, diagnostics, and end-of-life care — using the Schedule 1 names
• Separate price list for your most commonly sold parasiticides (Article 8)
• Prices presented in a format enabling consumer comparison (clear, not buried in footnotes, no "price on consultation" for listed services)
• Price list dated, with a "last updated" timestamp visible
• Update process documented — the Order requires the list to be updated before any revised price is charged (Article 7(5))
• Archived versions retained — for transparency and dispute resolution

The detail of which services must appear and exactly where the list has to be shown is in the CMA price list display rules.

In-practice display

• Equivalent price list visible in reception or waiting area
• Same content as website, same update cycle
• Accessible format (large print available on request, where reasonable)

Process control

• Named person responsible for price list maintenance
• SOP for price list updates — when, by whom, how change is communicated
• Audit log of changes (date, what changed, who authorised)

Workstream 2: itemised billing and estimates

Estimates

• Written estimate provided wherever the recommended treatment pathway is reasonably likely to cost £500 or more including VAT and more than £100 of it is still to come, by the end of the next working day — the CMA written estimate £500 rule covers the threshold and the 20%/£500 update trigger (in an emergency the Order defers the estimate until the emergency has ended; it does not remove it)
• Estimate includes line items — consultation, diagnostics, medications, procedures separately
• Estimate dated and signed (or digitally acknowledged) by client before treatment commences (where practicable)
• Estimate retained for at least 12 months, with a record of any factors that could change it (Article 11(11))
• Process for re-estimation if treatment scope changes mid-procedure
• Communication protocol for unexpected costs (consent for additional treatment, costs disclosed in advance)

Itemised invoices

• All invoices itemise consultation, diagnostics, medication, procedures separately
• Medications priced with quantity and unit price (not bundled into a generic "medication" line)
• Diagnostic procedures itemised (each test priced)
• Surgical procedures itemised (procedure, anaesthesia, post-op medication)
• No bundled "treatment package" lines without itemised breakdown available on request

The minimum line items every invoice must carry are set out in the CMA itemised bills rules.

Process control

• PMS/billing system configured to support itemised output (some legacy systems require update)
• Front-of-house staff trained on estimate process
• SOP for estimate creation, client communication, and post-treatment reconciliation

Workstream 3: ownership and corporate disclosure

Ownership disclosure

• Practice ownership clearly disclosed on website (independent, named corporate group, or specific parent entity)
• Group name on premises and storefront signage, homepage banner, page metadata, and search and map listings (Article 5 — applies to groups and to any business running more than one site)
• If part of a corporate group: which group, with appropriate visual or verbal disclosure
• Updates required on ownership change (mergers, acquisitions, share transfers)

Process control

• Named person responsible for ownership disclosure accuracy
• Process for updating disclosure on corporate change

Workstream 4: prescription, dispensing, and treatment information

Prescription transparency

• Clients informed of right to written prescription for medications (rather than purchase from the practice)
• Prescription fee (where charged) disclosed in advance and on the price list
• No undue restriction on prescriptions — practices cannot inflate prescription fees to discourage external dispensing

Generic vs proprietary

• When an own-brand medicine is prescribed, the owner is told so in the consultation and told that the reference product can be bought from third parties; the reference product is named in writing, on the label and on the invoice (Article 17)
• Practice's dispensing markup transparent if requested
• Cascade prescribing decisions documented and discussed with the client

Treatment information

• Treatment options presented with associated cost ranges (not just one option)
• Risks, benefits, and alternatives discussed and documented (already an RCVS Code of Professional Conduct requirement; CMA reinforces it)
• Out-of-hours arrangements clearly disclosed including any additional cost

Workstream 5: complaints and dispute resolution

Complaints process

• Documented complaints procedure publicly available (website + in-practice)
• Time-bound response commitments — the Order's figures are a written acknowledgement within 5 working days of a complaint becoming actionable (after ten working days without informal resolution), and a full letter of response within 8 weeks of that point, extendable to 12 weeks only by writing to the owner inside the 8 weeks (detail)
• Complaint log of actionable complaints, in the Order's Schedule 4 format, kept at least 12 months from resolution
• Trend analysis — recurring complaint themes captured and addressed

External redress

• Clients informed of right to escalate to the RCVS for professional conduct issues
• Clients informed of right to raise consumer complaints with appropriate authorities (Trading Standards, alternative dispute resolution body where applicable)
• An approved ADR provider offering mediation, free to pet owners, selected and named in the published process (Article 23)

Cross-cutting requirements

Beyond the workstream-specific items, several cross-cutting requirements follow from the Order:

• Staff training — every member of front-of-house staff trained on the new requirements, with training records (linked to your SOP and training framework)
• Audit cycle — quarterly self-audit against the checklist, findings documented, actions tracked (links to your clinical governance framework)
• Documentation retention — the Order sets at least 12 months for written estimates and for complaint log entries; keep itemised invoices in line with your normal accounting records
• Evidence pack — practice able to produce evidence of compliance on demand for CMA enquiries (analogous to VMD inspection readiness)

Pre-deadline timeline

Work forward from the Order rather than back from a single date. Each remedy has its own compliance date in Article 3 of the Order, and you must comply from the next working day after it. There is a fuller remedy-by-remedy version in how to prepare for the CMA vet Orders.

Now, to December 2026

• Audit current state against the checklist above

• Identify the largest gaps

• Establish ownership for each workstream

• Brief the team on what's coming

• Check your out-of-hours contract: since 23 September 2026 a provider cannot hold you to more than 12 months' notice

• Nothing on your own services is enforceable yet — this is the cheapest period in which to do the thinking

• Draft updated SOPs for estimates, complaints and prescription transparency

• Update risk assessments — pricing-related compliance is a new operational risk

• Start the PMS conversation for itemised billing; vendor release cycles are the long pole, not your own effort

• Watch the larger groups: their price lists are due from 23 December 2026, a full quarter before yours, and they show you what "compliant" looks like

By 22 March 2027 — first wave for a smaller practice

Three deadlines land together, and two of them give smaller practices no extra time.

• Publish the standardised price list on the website and display it in reception
• Complete ownership disclosure across website, signage and communications if you are in a group or run more than one site (all sizes — no extension)
• Publish the complaints process, with the 5-working-day and 8-week commitments, a named mediation provider and the complaint log behind it (all sizes — no extension)
• Run an internal audit against workstreams 1, 3 and 5

By 22 September 2027 — second wave for a smaller practice

• Written estimate process live in clinical workflow, staff trained, evidence retained
• PMS producing itemised invoices to the CMA's minimum line items
• Prescription fee cap applied in billing and shown on the price list
• Standard written-prescription notice, booking-message text, invoice footer and ongoing-medication flyer placed as the Order requires
• Run an internal audit against workstreams 2 and 4

Steady state, from late 2027

• Embed the checklist into your ongoing clinical governance audit cycle
• Annual review of the pricing transparency framework
• Track CMA enforcement signals — early enforcement actions will clarify what "compliant" means in practice

How CMA compliance integrates with wider compliance

CMA pricing transparency is a new compliance stream layered on top of the existing veterinary regulatory environment:

• SOP management — new SOPs for estimates, billing, complaints
• Risk assessments — pricing-related operational risks
• RCVS PSS — overlaps on client communication standards
• Clinical governance — CMA compliance is one stream within the framework
• Staff training and competency — front-of-house staff need new competencies

Practices that already have strong non-clinical compliance systems will find CMA compliance easier to integrate. Practices without an existing framework will find CMA the catalyst for building one — and if that means choosing a system, the guide to choosing vet compliance software sets out the criteria to test it against.

Getting started

The fastest start:

1. Run the CMA Compliance Self-Assessment tool to baseline current state across the CMA remedy areas
2. Identify the largest gaps — typically itemised billing and ownership disclosure are the easiest wins
3. Assign ownership for each workstream
4. Set the timeline — map each workstream to its own deadline (22 March 2027 for price lists, ownership and complaints; 22 September 2027 for estimates, bills and the prescription fee cap, for a smaller practice) rather than to a single date
5. Connect to your wider compliance framework — CMA isn't standalone; it sits within your governance structure

The enforcement picture will clarify through 2027 as the first deadlines pass and the CMA responds to what it finds. Practices that arrive at each deadline with a defensible system and documented evidence will be in a much better position than those waiting for full clarity before acting — and on this timetable there is enough runway to do it properly.

---

Reviewed 26 October 2026. The CMA made the Veterinary Services Market Investigation Order 2026 on 22 September 2026 and it came into force on 23 September 2026. Items above that cite an Order article, and every compliance date, are taken from the Order itself rather than from the draft consulted on in July and August 2026. Items without an article reference are good-practice controls, not Order requirements. This is not legal advice. For specific compliance queries, consult the Order and its Explanatory Note, the CMA's veterinary services case page, the British Veterinary Association's CMA guidance, and your defence body.